In short, through this study, we found that vitamin D treatment of RA may occur through antifolate resistance, osteoclast differentiation, and the NF-κB signaling pathway, acting on ALB, TNF, CASP3, and TP53 targets. Here, NFKB1 is linked to rheumatoid arthritis.